The US Food and Drug Administration on Thursday granted separate Emergency Use Authorizations (EUAs) for PCR-based SARS-CoV-2 tests developed by South Korean diagnostic test makers BioCore, SolGent, and Seasun Biomaterials.

Agilent Technologies reported after the close of the market on Thursday that its second quarter 2020 revenue growth was flat year over year.

The US Food and Drug Administration on Wednesday announced the approval of AstraZeneca and Merck's olaparib (Lynparza) for metastatic castration-resistant prostate cancer patients with homologous recombination repair deficiency.

Proteomics firm Nautilus Biotechnology announced Thursday it has closed an oversubscribed $76 million Series B financing round.

Northern and southern Italian populations began to diverge genetically thousands of years ago, according to a new study.

People in the News: Tony Serafini-Lamanna, Martin Chavez, Sun Kim, Oved Amitay, More

Host factors rather than viral genetic differences appear to influence disease outcomes among COVID-19 patients, according to a new study from China.

Roche said on Friday that it has acquired Seattle-based early-stage sequencing technology firm Stratos Genomics for an undisclosed amount in a bid to advance development of Roche's nanopore sequencer.

Regeneron Pharmaceuticals and the Colorado Center for Personalized Medicine (CCPM) said Monday

Quanterix said on Monday it has inked a non-exclusive agreement with Brigham and Women's Hospital for a SARS-CoV-2 serology test on its Simoa multiplex immunoassay platform.

People of different ancestral backgrounds can have different DNA methylation, mRNA, and microRNA expression levels

Castle Biosciences reported after the close of the market on Monday that it doubles its first quarter revenues year over year.

10x Genomics reported after the close of the market on Monday a 34 percent increase in first quarter revenues.

Researchers have isolated a coronavirus from Malayan pangolins that is highly similar to SARS-CoV-2, suggesting pangolins may have served as an intermediate host for the virus.

Grifols Diagnostic Solutions announced Thursday its Procelix Panther System featuring Automation Ready Technology (ART) received approval from the US Food and Drug Administration.